Evidence map›Paper›PMID 40864462›Full record

Trial reportJAMA cardiology2025

Iodinated Adhesive Drapes for Repeat Cardiac Implantable Device Implantation: A Randomized Clinical Trial.

Alper Aydin, Mehrdad Golian, Andres Klein, Calum Redpath, Darryl R Davis, F Daniel Ramirez, Girish M Nair, Martin S Green, Mouhannad Sadek, Pablo B Nery and 15 more

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in JAMA cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04591366 (Barrier-Protect Study), which is not on this map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04591366 naactive not recruitingnot on this map

Barrier-Protect Study: Do Barrier Dressings Reduce Device Infection: a Pilot, Randomized Controlled Trial

TypeinterventionalSponsorOttawa Heart Institute Research CorporationRan2020 to 2027Enrolled390ConditionsInfectionArmsBarrier dressing
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Alper AydinDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Mehrdad GolianDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Andres KleinDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Calum RedpathDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Darryl R DavisDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
F Daniel RamirezDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Girish M NairDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Martin S GreenDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Mouhannad SadekDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Pablo B NeryDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Simon P HansomDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Ghalib Al HinaiDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Willy WengDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Nicolas BerbenetzDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Michael J ThibertDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Yasmeen SalmeenDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Evan MartowDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Li Wei TanDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Ghaith AlmidaniDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Abdullah AlshehriDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Anas AlzahraniDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Fahad AlharbiDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Vicente Corrales-MedinaDivision of Infectious Diseases, Department of Medicine, University of Ottawa, and The Ottawa Hospital, Ottawa, Ontario, Canada.
George A WellsDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
David H BirnieDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: One potential pathophysiological mechanism for cardiac implantable electronic device (CIED) infections is pocket contamination during the implantation procedure. Preventing contamination at this stage may significantly reduce the risk of infections. Objective: To determine whether the application of an intraoperative adhesive iodine-impregnated drape would reduce the rate of end-of-procedure pocket-swab positivity and subsequent CIED infections. Design, Setting, and Participants: This was a prospective, double-armed, single-blinded, randomized clinical trial, conducted from November 2020 to May 2024. Patients, the staff performing the swabs, and the microbiologists were blinded to group assignments. This was a single-center study that included patients undergoing repeat procedures on the same device pocket. These patients were randomized in a 1:1 ratio to either the iodine-impregnated drape group or the control group. Intervention: Application of an iodine-impregnated drape at the beginning of the procedure. Main Outcomes and Measures: The primary end point was end-of-procedure pocket-swab culture positivity. Results: A total of 418 patients were randomized (210 to the drape group and 208 to the no-drape group). The final analysis included 189 patients in the drape group and 195 patients in the no-drape group, with both groups well balanced in demographics. In the drape group, 143 participants were male (75.7%), and mean (SD) age was 73.9 (12.1) years; in the no-drape group, 140 were male (71.8%), and mean (SD) age was 73.2 (12.6) years. Pocket-swab culture positivity was found in 19 of 189 patients (10.1%) in the drape group compared with 40 of 195 patients (20.5%) in the no-drape group (relative risk reduction [RRR], 0.50; 95% CI, 0.24-0.75; P = .005). Adjudicated CIED infections occurred in 4 of 195 patients (1.9%) in the no-drape group vs 0 of 189 in the drape group (P = .02). CIED infections were observed in 2 of 59 patients (3.4%) with positive swabs and in 2 of 325 patients (0.6%) with negative swabs (odds ratio, 5.67; 95% CI, 0.78-41.04; P = .08). Conclusions and Relevance: In this randomized clinical trial, the use of iodine-impregnated drapes during repeat CIED implantation resulted in reduction in swab culture positivity and 1-year CIED infection rates. This is a simple and cost-effective intervention to reduce CIED pocket contamination and subsequent infections. Trial Registration: ClinicalTrials.gov Identifier: NCT04591366.

Indexed as

AdhesivesAnti-Infective Agents, LocalDefibrillators, ImplantableIodinePacemaker, ArtificialProsthesis-Related InfectionsSurgical DrapesAgedDouble-Blind MethodFemaleHumansMaleMiddle AgedPilot ProjectsProspective StudiesReoperationAdhesivesAnti-Infective Agents, LocalIodine

Identifiers

PMID40864462
PMCPMC12392146

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.